Grace Therapeutics, Inc.(GRCE)Earnings Date, History & Expected Move

Next report
Nov 16, 2026

GRCE is scheduled to report on Nov 16, 2026, usually before the market opens. Analysts expect EPS of -$0.15.

Next report
Nov 16, 2026
In 23 days · usually before open
EPS beat rate
83%
10 of 12 quarters
Avg move after earnings
±3.4%
Up 42% of the time · last 12
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 12 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±3.4%).

Did the stock rise after good news?

The next-day move after each of its last 10 EPS beats and 1 misses.

When it beat expectations
10 reports
When it missed expectations
1 report

In plain words: it beat expectations 10 times, but the stock still fell 5 of those 10 times.

Report by report
  • Jun '26
    Beat
    ▲ +7.2%
  • Feb '26
    Beat
    ▼ -1.7%
  • Nov '25
    Beat
    ▲ +2.3%
  • Aug '25
    Beat
    ▲ +3.5%
  • Jun '25
    Beat
    ▼ -2.3%
  • Feb '25
    Missed
    ▼ 0.0%
  • Nov '24
    Beat
    ▼ -4.4%
  • Aug '24
    Beat
    ▼ -3.3%
  • Jun '24
    Beat
    ▲ +4.8%
  • Feb '24
    Beat
    ▲ +6.5%
  • Nov '23
    Beat
    ▼ -3.2%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
+1.0%
average next-day move · up 50% of 10 times
After an EPS miss
—
Not enough quarters yet

Why did GRCE fall after beating earnings?

5 of GRCE's last 11 reactions went against the EPS result. What stands out in each:

GRCE beat EPS estimates in 10 quarters, and the stock still closed lower the next day 5 times. In 1 of the 5 where we have price data, the stock had already run up before the report.

  • Feb 12, 2026EPS beat +51.3%stock -1.7% next day
    • It opened 1.7% higher, but sellers took over and it closed -1.7%.
  • Jun 23, 2025EPS beat +135.0%stock -2.3% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Nov 13, 2024EPS beat +16.0%stock -4.4% next day
    • It had risen 4.9% in the final week before the report, so good news may already have been priced in.
    • It opened 2.5% lower as soon as trading resumed.
  • Aug 9, 2024EPS beat +8.3%stock -3.3% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Nov 13, 2023EPS beat +11.4%stock -3.2% next day
    • It opened 3.6% lower as soon as trading resumed.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was GRCE's earnings move already priced in?

GRCE's move in the month before each of its last 12 reports, against what it did after.

Avg move in the month before
-4.3%
last 12 reports
Higher before the report
33%
of the time
After a drop of 3%+
Rose 33%
6 reports, avg -0.4%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 12 reports. Green or red: the day after.

Past reports only. How the run-up is measured

Does GRCE hold its opening gap after earnings?

GRCE's opening move after each report and where it closed that day.

In 4 reports GRCE opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 4 times (50%), and fully reversed 1 time.

  • Feb 12, 2026Reversed
    Opened +1.7%, closed -1.7%
  • Feb 13, 2025Faded
    Opened -2.6%, closed 0.0%
  • Nov 13, 2024Held
    Opened -2.5%, closed -4.4%
  • Nov 13, 2023Held
    Opened -3.6%, closed -3.2%

How gaps, fades and reversals are defined

What the history says

  • It fell after 5 of its 10 EPS beats (50%): beating estimates has not been enough on its own.

GRCE earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurprise1-day move3-day move
Aug 13, 2026Before open-$0.18-$0.180.0%-1.43%+2.86%
Jun 18, 2026Before open-$0.20-$0.08+60.0%+7.21%+7.66%
Feb 12, 2026Before open-$0.39-$0.19+51.3%-1.67%+9.75%
Nov 13, 2025Before open-$0.34-$0.08+76.5%+2.31%-0.99%
Aug 12, 2025Before open-$0.31-$0.29+6.5%+3.55%-0.65%
Jun 23, 2025Before open-$0.40$0.14+135.0%-2.33%-1.33%
Feb 13, 2025Before open-$0.46-$0.51-10.9%0.00%-1.72%
Nov 13, 2024Before open-$0.50-$0.42+16.0%-4.39%-2.51%
Aug 9, 2024Before open-$0.36-$0.33+8.3%-3.28%-2.05%
Jun 21, 2024Before open-$0.47-$0.36+23.4%+4.76%-1.59%
Feb 12, 2024Before open-$0.31-$0.28+9.7%+6.53%+7.76%
Nov 13, 2023Before open-$0.35-$0.31+11.4%-3.15%-1.80%

Consensus for the next report: EPS -$0.15, revenue $0.00.

GRCE Earnings FAQ

Answers computed from Grace Therapeutics, Inc.'s reported history

GRCE is scheduled to report on Nov 16, 2026, usually before the market opens. Analysts expect EPS of -$0.15.

Over the last 12 quarters with a usable EPS surprise, GRCE beat the consensus estimate 10 times (83%), missed 1 and landed in line 1.

Across its last 12 quarters with a measured reaction, GRCE moved an average of ±3.4% in the first session after reporting. It closed higher 42% of the time; the largest gain was 7.2% and the largest drop -4.4%.

GRCE fell in the first session after 5 of its last 10 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 5 of those falls where price data is available, the stock had already risen before the report.

Across its last 12 quarters with price data, GRCE moved an average of -4.3% in the 20 trading sessions before reporting and was higher in 33% of them. After a drop of 3% or more (6 quarters), it rose the next day 33% of the time, averaging -0.4%. This describes past reports; it is not a forecast.

In 4 reports GRCE opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 4 times (50%), and fully reversed once. A fade means the opening move was partly undone during the first session.

How we calculate these numbers · GRCE: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.

Looking for more on GRCE?

Price charts, forecast, fundamentals and risk pages for GRCE are not on Tickzen yet. You can run a full stock analysis now.

Run the GRCE Stock Analyzer